PMID- 23922842 OWN - NLM STAT- MEDLINE DCOM- 20140429 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 8 IP - 7 DP - 2013 TI - Biochemical characterization of a polysialyltransferase from Mannheimia haemolytica A2 and comparison to other bacterial polysialyltransferases. PG - e69888 LID - 10.1371/journal.pone.0069888 [doi] LID - e69888 AB - Polysialic acids are bioactive carbohydrates found in eukaryotes and some bacterial pathogens. The bacterial polysialyltransferases (PSTs), which catalyze the synthesis of polysialic acid capsules, have previously been identified in select strains of Escherichia coli and Neisseria meningitidis and are classified in the Carbohydrate-Active enZYmes Database as glycosyltransferase family GT-38. In this study using DNA sequence analysis and functional characterization we have identified a novel polysialyltransferase from the bovine/ovine pathogen Mannheimia haemolytica A2 (PSTMh). The enzyme was expressed in recombinant form as a soluble maltose-binding-protein fusion in parallel with the related PSTs from E. coli K1 and N. meningitidis group B in order to perform a side-by-side comparison. Biochemical properties including solubility, acceptor preference, reaction pH optima, thermostability, kinetics, and product chain length for the enzymes were compared using a synthetic fluorescent acceptor molecule. PSTMh exhibited biochemical properties that make it an attractive candidate for chemi-enzymatic synthesis applications of polysialic acid. The activity of PSTMh was examined on a model glycoprotein and the surface of a neuroprogenitor cell line where the results supported its development for use in applications to therapeutic protein modification and cell surface glycan remodelling to enable cell migration at implantation sites to promote wound healing. The three PSTs examined here demonstrated different properties that would each be useful to therapeutic applications. FAU - Lindhout, Theresa AU - Lindhout T AD - Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada. FAU - Bainbridge, Cynthia R AU - Bainbridge CR FAU - Costain, Will J AU - Costain WJ FAU - Gilbert, Michel AU - Gilbert M FAU - Wakarchuk, Warren W AU - Wakarchuk WW LA - eng GR - MOP-84272/Canadian Institutes of Health Research/Canada PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130726 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Bacterial Proteins) RN - 0 (Fetuins) RN - 0 (Recombinant Proteins) RN - 0 (Sialic Acids) RN - 0 (cytidine-5'-diphosphosialic acid) RN - 0 (polysialic acid) RN - 63-38-7 (Cytidine Diphosphate) RN - EC 2.4.99.- (Sialyltransferases) SB - IM MH - Animals MH - Bacterial Proteins/metabolism MH - Cell Membrane/metabolism MH - Cytidine Diphosphate/analogs & derivatives/metabolism MH - Electrophoresis, Capillary MH - Electrophoresis, Polyacrylamide Gel MH - Enzyme Stability MH - Escherichia coli/*enzymology MH - Fetuins/metabolism MH - Genome, Bacterial/genetics MH - Hydrogen-Ion Concentration MH - Kinetics MH - Mannheimia haemolytica/*enzymology/genetics MH - Neisseria meningitidis, Serogroup B/*enzymology MH - PC12 Cells MH - Rats MH - Recombinant Proteins/metabolism MH - Sialic Acids/metabolism MH - Sialyltransferases/*metabolism MH - Solubility MH - Temperature MH - Time Factors PMC - PMC3724679 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2013/08/08 06:00 MHDA- 2014/04/30 06:00 PMCR- 2013/07/26 CRDT- 2013/08/08 06:00 PHST- 2013/03/27 00:00 [received] PHST- 2013/06/13 00:00 [accepted] PHST- 2013/08/08 06:00 [entrez] PHST- 2013/08/08 06:00 [pubmed] PHST- 2014/04/30 06:00 [medline] PHST- 2013/07/26 00:00 [pmc-release] AID - PONE-D-13-12726 [pii] AID - 10.1371/journal.pone.0069888 [doi] PST - epublish SO - PLoS One. 2013 Jul 26;8(7):e69888. doi: 10.1371/journal.pone.0069888. Print 2013.